Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1348, Iss. 1, 2015-08 ,pp. : 1-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?

By Marini Francesca   Cianferotti Luisella   Brandi Maria Luisa  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1329-1329

MDPI

Access to resources Recommend Favorite

Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models

By  

JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29, Iss. 12, 2014-12 ,pp. : 2688-2696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fasting Enhances the Contrast of Bone Metastatic Lesions in ¹⁸F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases

By Oka Shuntaro   Kanagawa Masaru   Doi Yoshihiro   Schuster David M.   Goodman Mark M.   Yoshimura Hirokatsu  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 934-934

MDPI

Access to resources Recommend Favorite

Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities

By Popa-Wagner Aurel   Glavan Daniela-Gabriela   Olaru Andrei   Olaru Denissa-Greta   Margaritescu Otilia   Tica Oana   Surugiu Roxana   Sandu Raluca Elena  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 356-356

MDPI

Access to resources Recommend Favorite